Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection
Thursday, June 27, 2024Vir Biotechnology Inc today announced that the US Food and Drug Administration has cleared its investigational new drug application and granted Fast Track designation for the combination
Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis
Thursday, June 27, 2024Synaptogenix Inc an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders today announced that the Food Drug Administration
Tempus Announces Collaboration with United Therapeutics to Study Use of AI to Detect Patients at Risk for Pulmonary Hypertension
Wednesday, June 26, 2024Tempus AI Inc a leader in artificial intelligence and precision medicine today announced a new collaboration with United Therapeutics a leading biotechnology
Halozyme Announces Roche's OCREVUS® SC with ENHANZE® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Wednesday, June 26, 2024Halozyme Therapeutics Inc today announced that Roche received European Commission marketing authorization of OCREVUS SC coformulated
Novo Nordisk Announces 4.1 Billion USD Investment to Expand US Manufacturing Capacity
Tuesday, June 25, 2024Novo Nordisk today announced plans to invest billion US dollars to build a second fill and finishing manufacturing facility in Clayton North Carolina and grow its ability to produce current and future injectable treatments
Rigel Pharmaceuticals Completes Transfer of GAVRETO® (pralsetinib) New Drug Application
Tuesday, June 25, 2024Rigel Pharmaceuticals Inc today announced the completion of the transfer to Rigel of the New Drug Application for GAVRETO for the treatment of adult patients with metastatic rearranged during transfection
Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine
Tuesday, June 25, 2024Novavax Inc a global company advancing proteinbased vaccines with its MatrixM adjuvant today announced that it has filed for a type II variation of existing
On Path to First-in-Human Study, NurExone Engages Prominent Expert in Biological Drug Development
Monday, June 24, 2024NurExone Biologic Inc a pioneering biopharmaceutical company welcomes Dr Yona Geffen as a consultant to support the Companys preclinical and clinical activities Dr Geffen who currently
HUTCHMED Announces European Commission Approval for FRUZAQLA® (fruquintinib) Received by Takeda
Saturday, June 22, 2024HUTCHMED Limited today announces that its partner Takeda has received notification from the European Commission that it has approved FRUZAQLA as a monotherapy indicated for the treatment of adult patients with metastatic
Coya Therapeutics Expands Research Collaboration with Houston Methodist and Secures Funding to Advance T Cell Exosome Platform
Friday, June 21, 2024Coya Therapeutics Inc a clinicalstage biotechnology company developing biologics intended to enhance regulatory T cell function announces the expansion
